Earth Science Tech Inc. (OTC: ETST) is advancing a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine, clinical support, and fulfillment, aiming for dilution-free and cash-flow-driven growth. The company's strategy relies on the synergy of its specialized subsidiaries: RxCompoundStore (RxCS), Mister Meds, and Peaks Curative LLC.
RxCS, a Miami-based licensed compounding pharmacy, produces sterile and non-sterile medications. Mister Meds, based in Abilene, Texas, focuses on sterile medications and hazardous drugs. Together, these pharmacies compound ingredients to create custom medications supplied wholesale to independent clinics and directly to consumers through Peaks Curative LLC, ETST's telemedicine and clinical support subsidiary. This dual-market operation reduces reliance on any single market segment, according to the company.
The integrated model allows Earth Science Tech to control the entire patient care cycle—from consultation via telemedicine to the fulfillment of custom medications. In fiscal year 2026, the company reduced total liabilities and increased total assets, resulting in a net increase in shareholder equity, underscoring the effectiveness of its cash-flow-driven approach.
Earth Science Tech's focus on vertical integration in healthcare is significant as it aims to capture value across multiple points in the care delivery process. By owning the compounding pharmacies and the distribution channel, the company can potentially improve margins and ensure quality control. The reduction in liabilities and growth in assets signals financial discipline, which is crucial for a holding company operating in the competitive healthcare sector.
For investors, the company's strategy offers a potential path to growth without diluting existing shareholders. The latest news and updates relating to ETST are available in the company’s newsroom at https://ibn.fm/ETST.
This press release was syndicated by InvestorWire, a platform that distributes press releases for private and public companies. More information about InvestorWire can be found at https://www.InvestorWire.com. The full terms of use and disclaimers are available at https://www.InvestorWire.com/Disclaimer.
